(S)-2-(2-((3'-(1-Amino-2-hydroxyethyl)-5-(isopropylamino)-[1,1'-biphenyl]-3-yl)methoxy)phenyl)acetic Acid

ID: ALA4463116

Chembl Id: CHEMBL4463116

PubChem CID: 117820116

Max Phase: Preclinical

Molecular Formula: C26H30N2O4

Molecular Weight: 434.54

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)Nc1cc(COc2ccccc2CC(=O)O)cc(-c2cccc([C@H](N)CO)c2)c1

Standard InChI:  InChI=1S/C26H30N2O4/c1-17(2)28-23-11-18(16-32-25-9-4-3-6-21(25)14-26(30)31)10-22(13-23)19-7-5-8-20(12-19)24(27)15-29/h3-13,17,24,28-29H,14-16,27H2,1-2H3,(H,30,31)/t24-/m1/s1

Standard InChI Key:  RYXYOJVPYQZGGE-XMMPIXPASA-N

Associated Targets(Human)

CFD Tchem Complement factor D (1353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F11 Tchem Coagulation factor XI (1733 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TPSB2 Tchem Tryptase beta-2 (22 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 434.54Molecular Weight (Monoisotopic): 434.2206AlogP: 4.37#Rotatable Bonds: 10
Polar Surface Area: 104.81Molecular Species: ZWITTERIONHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 3.85CX Basic pKa: 8.89CX LogP: 1.30CX LogD: 1.29
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.38Np Likeness Score: -0.46

References

1. Karki RG, Powers J, Mainolfi N, Anderson K, Belanger DB, Liu D, Ji N, Jendza K, Gelin CF, Mac Sweeney A, Solovay C, Delgado O, Crowley M, Liao SM, Argikar UA, Flohr S, La Bonte LR, Lorthiois EL, Vulpetti A, Brown A, Long D, Prentiss M, Gradoux N, de Erkenez A, Cumin F, Adams C, Jaffee B, Mogi M..  (2019)  Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway.,  62  (9): [PMID:30995036] [10.1021/acs.jmedchem.9b00271]

Source